{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:07:39Z","timestamp":1791925659099,"version":"4.3.4"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T00:00:00Z","timestamp":1627257600000},"content-version":"vor","delay-in-days":206,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Pharmacology and Drug Discovery"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.crphar.2021.100042","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T11:48:55Z","timestamp":1627472935000},"page":"100042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2"],"prefix":"10.1016","volume":"2","author":[{"given":"Kartikay","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3621-5025","authenticated-orcid":false,"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crphar.2021.100042_bib1","first-page":"928","article-title":"Drug repurposing study pinpoints potential COVID-19 antivirals","volume":"324","author":"Abbasi","year":"2020","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.crphar.2021.100042_bib3","unstructured":"Ableton Live Digital Audio Workstation, https:\/\/www.ableton.com\/en\/live\/, (2020)."},{"issue":"7","key":"10.1016\/j.crphar.2021.100042_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202000034","article-title":"Project IDentif. AI: harnessing artificial intelligence to rapidly optimize combination therapy development for infectious disease intervention","volume":"3","author":"Abdulla","year":"2020","journal-title":"Advanced Therapeutics"},{"key":"10.1016\/j.crphar.2021.100042_bib4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1152\/physiolgenomics.00029.2020","article-title":"Artificial intelligence and machine learning to fight COVID-19","volume":"52","author":"Alimadadi","year":"2020","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.crphar.2021.100042_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240149","article-title":"In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm","volume":"15","author":"Artigas","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.crphar.2021.100042_bib6","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1021\/acs.jpclett.0c02278","article-title":"Screening of therapeutic Agents for COVID-19 using machine learning and ensemble docking studies","volume":"11","author":"Batra","year":"2020","journal-title":"J.\u00a0Phys. Chem. Lett."},{"key":"10.1016\/j.crphar.2021.100042_bib7","series-title":"Improving deep reinforcement learning with Transitional variational autoencoders: a healthcare application","author":"Baucum","year":"2020"},{"key":"10.1016\/j.crphar.2021.100042_bib8","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.csbj.2020.03.025","article-title":"Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model","volume":"18","author":"Beck","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.crphar.2021.100042_bib9","article-title":"For SARS-CoV-2 disease using a novel molecular modeling-AI hybrid Workflow","author":"Bembenek","year":"2020","journal-title":"ChemRxiv Preprint"},{"key":"10.1016\/j.crphar.2021.100042_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10196","article-title":"IDentif.AI: rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development","volume":"6","author":"Blasiak","year":"2021","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.crphar.2021.100042_bib11","first-page":"236528","article-title":"Comparative pathogenesis and systems biology for biodefense virus vaccine development","volume":"2010","author":"Bowick","year":"2010","journal-title":"J.\u00a0Biomed. Biotechnol."},{"key":"10.1016\/j.crphar.2021.100042_bib12","article-title":"Nanomechanical sonification of the 2019-nCoV coronavirus spike protein through a materiomusical approach","author":"Buehler","year":"2020","journal-title":"arXiv"},{"key":"10.1016\/j.crphar.2021.100042_bib13","article-title":"A, de novo design of new chemical entities (NCEs) for SARS-CoV-2 using artificial intelligence","author":"Bung","year":"2020","journal-title":"ChemRxiv Preprint"},{"key":"10.1016\/j.crphar.2021.100042_bib14","article-title":"Machine-learning driven drug repurposing for covid-19","author":"Cant\u00fcrk","year":"2020","journal-title":"arXiv"},{"key":"10.1016\/j.crphar.2021.100042_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26071912","article-title":"Development of pulmonary hypertension therapies for COVID-19 treatment using an AI-integrated Biosimulation platform","volume":"26","author":"Chakravarty","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.crphar.2021.100042_bib16","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.drudis.2018.01.039","article-title":"The rise of deep learning in drug discovery","volume":"23","author":"Chen","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.crphar.2021.100042_bib17","article-title":"Design for COVID-19 using deep generative models","author":"Chenthamarakshan","year":"2020","journal-title":"arXiv preprint"},{"key":"10.1016\/j.crphar.2021.100042_bib18","article-title":"Leverging deep learning to simulate coronavirus spike proteins has the potential to predict future Zoonotic sequences","author":"Crossman","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.crphar.2021.100042_bib19","doi-asserted-by":"crossref","first-page":"100077","DOI":"10.1016\/j.medidd.2020.100077","article-title":"AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate","volume":"9","author":"Delijewski","year":"2021","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.crphar.2021.100042_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.crphar.2021.100042_bib21","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/bioinformatics\/btu847","article-title":"The anisotropic network model web server at 2015 (ANM 2.0)","volume":"31","author":"Eyal","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.crphar.2021.100042_bib22","article-title":"Of 2019-nCoV","author":"Fast","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.crphar.2021.100042_bib23","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1038\/d41586-018-05267-x","article-title":"How artificial intelligence is changing drug discovery","volume":"557","author":"Fleming","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.crphar.2021.100042_bib24","first-page":"375","article-title":"In coronavirus Capitalism. tripleC: Communication, Capitalism & Critique","volume":"18","author":"Fuchs","year":"2020","journal-title":"Journal for a Global Sustainable Information Society"},{"key":"10.1016\/j.crphar.2021.100042_bib25","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1021\/acs.jpclett.0c01579","article-title":"Repositioning of 8565 existing drugs for COVID-19","volume":"11","author":"Gao","year":"2020","journal-title":"J.\u00a0Phys. Chem. Lett."},{"key":"10.1016\/j.crphar.2021.100042_bib26","article-title":"Shen X, Z. J, A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19","author":"Ge","year":"2020","journal-title":"bioRxiv preprint"},{"key":"10.1016\/j.crphar.2021.100042_bib27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1039\/C9SC04026A","article-title":"Constrained Bayesian optimization for automatic chemical design using variational autoencoders","volume":"11","author":"Griffiths","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.crphar.2021.100042_bib28","article-title":"Network medicine framework for identifying drug repurposing opportunities for COVID-19","author":"Gysi","year":"2020","journal-title":"arXiv"},{"key":"10.1016\/j.crphar.2021.100042_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007449","article-title":"Ten quick tips for homology modeling of high-resolution protein 3D structures","volume":"16","author":"Haddad","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.crphar.2021.100042_bib30","article-title":"Modeling of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins by machine learning and physics-based Refinement","author":"Heo","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.crphar.2021.100042_bib31","article-title":"Hochreiter S, K. G, Large-scale ligand-based virtual screening for SARS-CoV-2 inhibitors using deep neural networks","author":"Hofmarcher","year":"2020","journal-title":"arXiv"},{"key":"10.1016\/j.crphar.2021.100042_bib32","article-title":"J., BERE: an accurate distantly supervised biomedical entity relation extraction network","author":"Hong","year":"2019","journal-title":"arXiv preprint"},{"key":"10.1016\/j.crphar.2021.100042_bib33","unstructured":"https:www.dimensions.ai\/, (Accessed on 01 September 2020.)."},{"key":"10.1016\/j.crphar.2021.100042_bib34","article-title":"P., prediction of potential commercially inhibitors against SARS-CoV-2 by multi-Task deep model","author":"Hu","year":"2020","journal-title":"arXiv preprint"},{"key":"10.1016\/j.crphar.2021.100042_bib35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"22-23","key":"10.1016\/j.crphar.2021.100042_bib36","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1093\/bioinformatics\/btaa1005","article-title":"DeepPurpose: a deep learning library for drug-target interaction prediction","volume":"36","author":"Huang","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.crphar.2021.100042_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228926","article-title":"In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan","volume":"15","author":"Jorba","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.crphar.2021.100042_bib38","article-title":"a.t.A. team., Computational predictions of protein structures associated with COVID-19","author":"Jumper","year":"2020","journal-title":"DeepMind website"},{"key":"10.1016\/j.crphar.2021.100042_bib39","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.16.2100413","article-title":"Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021","volume":"26","author":"Jungnick","year":"2021","journal-title":"Euro Surveill."},{"issue":"4","key":"10.1016\/j.crphar.2021.100042_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2020.05.001","article-title":"Artificial intelligence approach fighting COVID-19 with repurposing drugs","volume":"43","author":"Ke","year":"2020","journal-title":"Biomed. J."},{"key":"10.1016\/j.crphar.2021.100042_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/frai.2020.00065","article-title":"Artificial intelligence for COVID-19 drug discovery and vaccine development","volume":"3","author":"Keshavarzi Arshadi","year":"2020","journal-title":"Front. Artif. Intell."},{"key":"10.1016\/j.crphar.2021.100042_bib42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s13365-020-00895-4","article-title":"Neurological manifestations of COVID-19: available evidences and a new paradigm","volume":"26","author":"Khatoon","year":"2020","journal-title":"J.\u00a0Neurovirol."},{"key":"10.1016\/j.crphar.2021.100042_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e04639","article-title":"Predicting novel drugs for SARS-CoV-2 using machine learning from a >10 million chemical space","volume":"6","author":"Kowalewski","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.crphar.2021.100042_bib44","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/prot.21117","article-title":"PIPER: an FFT-based protein docking program with pairwise potentials","volume":"65","author":"Kozakov","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.crphar.2021.100042_bib45","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41580-019-0163-x","article-title":"Advances in protein structure prediction and design","volume":"20","author":"Kuhlman","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.crphar.2021.100042_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40246-020-00297-x","article-title":"Network machine learning maps phytochemically rich \"Hyperfoods\" to fight COVID-19","volume":"15","author":"Laponogov","year":"2021","journal-title":"Hum. Genom."},{"key":"10.1016\/j.crphar.2021.100042_bib47","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.drudis.2019.07.006","article-title":"Deep learning in drug discovery: opportunities, challenges and future prospects","volume":"24","author":"Lavecchia","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.crphar.2021.100042_bib48","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/prot.25798","article-title":"Ensembling multiple raw coevolutionary features with deep residual neural networks for contact-map prediction in CASP13","volume":"87","author":"Li","year":"2019","journal-title":"Proteins"},{"key":"10.1016\/j.crphar.2021.100042_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration,","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.crphar.2021.100042_bib50","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.crphar.2021.100042_bib51","article-title":"Repurposing therapeutics for COVID-19: rapid prediction of commercially available drugs through machine learning and docking","author":"Mahapatra","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.crphar.2021.100042_bib52","doi-asserted-by":"crossref","first-page":"22375","DOI":"10.1038\/s41598-020-78758-5","article-title":"Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs","volume":"10","author":"Malone","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crphar.2021.100042_bib53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-3527(06)66005-3","article-title":"The molecular biology of coronaviruses","volume":"66","author":"Masters","year":"2006","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.crphar.2021.100042_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0931-3","article-title":"Artificial intelligence-enabled rapid diagnosis of patients with COVID-19","author":"Mei","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.crphar.2021.100042_bib55","doi-asserted-by":"crossref","first-page":"100526","DOI":"10.1016\/j.imu.2021.100526","article-title":"Contribution of machine learning approaches in response to SARS-CoV-2 infection","volume":"23","author":"Mottaqi","year":"2021","journal-title":"Inform Med Unlocked"},{"key":"10.1016\/j.crphar.2021.100042_bib56","article-title":"Artificial intelligence in the battle against coronavirus (COVID-19): a survey and future research directions","author":"Nguyen","year":"2020","journal-title":"Preprint"},{"key":"10.1016\/j.crphar.2021.100042_bib57","article-title":"Potentially highly potent drugs for 2019-nCoV","author":"Nguyen","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.crphar.2021.100042_bib58","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1093\/bioinformatics\/btaa119","article-title":"Vaxign-ML: supervised machine learning reverse vaccinology model for improved prediction of bacterial protective antigens","volume":"36","author":"Ong","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.crphar.2021.100042_bib59","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fimmu.2020.01581","article-title":"COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning","volume":"11","author":"Ong","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.crphar.2021.100042_bib60","first-page":"1","article-title":"The role of artificial intelligence in fighting the COVID-19 pandemic","author":"Piccialli","year":"2021","journal-title":"Inf. Syst. Front"},{"key":"10.1016\/j.crphar.2021.100042_bib61","doi-asserted-by":"crossref","first-page":"20465","DOI":"10.1038\/s41598-020-77466-4","article-title":"Identification and validation of 174 COVID-19 vaccine candidate epitopes reveals low performance of common epitope prediction tools","volume":"10","author":"Prachar","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crphar.2021.100042_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2020.06.228","article-title":"Targeting hub genes and pathways of innate immune response in COVID-19: a network biology perspective","volume":"163","author":"Prasad","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.crphar.2021.100042_bib63","article-title":"Analysis of the vibrational and sound spectrum of over 100,000 protein structures and application in sonification","volume":"100460","author":"Qin","year":"2019","journal-title":"Extrem. Mech. Lett."},{"key":"10.1016\/j.crphar.2021.100042_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.artmed.2018.12.010","article-title":"Antigenic: an improved prediction model of protective antigens","volume":"94","author":"Rahman","year":"2019","journal-title":"Artif. Intell. Med."},{"key":"10.1016\/j.crphar.2021.100042_bib65","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9572","article-title":"A.S.M. Rubayet Ul Alam, M.A. Siddique, O. Saha, M.M. Rahaman, M. Sultana, K.A. Crandall, M.A. Hossain, Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach","volume":"8","author":"Rahman","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.crphar.2021.100042_bib66","article-title":"PolypharmDB, a deep learning-based resource, quickly identifies repurposed drug candidates for COVID-19","author":"Redka","year":"2020","journal-title":"ChemRxiv Preprint"},{"key":"10.1016\/j.crphar.2021.100042_bib67","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.crphar.2021.100042_bib68","article-title":"The essential Facts of Wuhan novel coronavirus outbreak in China and epitope-based vaccine designing against 2019-nCoV","author":"Sarkar","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.crphar.2021.100042_bib69","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/prot.25834","article-title":"Protein structure prediction using multiple deep neural networks in the 13th Critical Assessment of Protein Structure Prediction (CASP13)","volume":"87","author":"Senior","year":"2019","journal-title":"Proteins"},{"key":"10.1016\/j.crphar.2021.100042_bib70","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-019-1923-7","article-title":"Improved protein structure prediction using potentials from deep learning","volume":"577","author":"Senior","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crphar.2021.100042_bib71","article-title":"Todd Young, John Gounley, Christopher Stanley, a.D. Bhowmik, distinct structural flexibility within SARS-CoV-2 spike protein reveals potential therapeutic targets","author":"Serena","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.crphar.2021.100042_bib72","article-title":"Repurposing therapeutics for COVID-19: Supercomputer-based docking to the SARS-CoV-2 viral spike protein and viral spike protein-human ACE2 interface","author":"Smith","year":"2020","journal-title":"ChemRxiv Preprint"},{"key":"10.1016\/j.crphar.2021.100042_bib73","unstructured":"SoundCloud.com, https:\/\/soundcloud.com\/user-275864738\/viral-counterpoint-of-the-coronavirus-spike-protein-2019-ncov?in=user-275864738\/sets\/protein-counterpoint."},{"key":"10.1016\/j.crphar.2021.100042_bib74","article-title":"AI-aided design of novel targeted covalent inhibitors against SARS-CoV-2","author":"Tang","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.crphar.2021.100042_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202000028","article-title":"Rapid identification of potential inhibitors of SARS-CoV-2 main protease by deep docking of 1.3 Billion compounds","author":"Ton","year":"2020","journal-title":"Mol Inform"},{"key":"10.1016\/j.crphar.2021.100042_bib76","article-title":"Deep Graph Library: Towards Efficient and Scalable Deep Learning On graphs","author":"Wang","year":"2019","journal-title":"ArXiv"},{"key":"10.1016\/j.crphar.2021.100042_bib77","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.crphar.2021.100042_bib78","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A\u00a0new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.crphar.2021.100042_bib79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER Suite: protein structure and function prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.crphar.2021.100042_bib80","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1073\/pnas.1914677117","article-title":"Improved protein structure prediction using predicted interresidue orientations","volume":"117","author":"Yang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.crphar.2021.100042_bib81","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1021\/acs.jproteome.0c00316","article-title":"Repurpose open data to discover therapeutics for COVID-19 using deep learning","author":"Zeng","year":"2020","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.crphar.2021.100042_bib82","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymeth.2019.02.021","article-title":"Exploring semi-supervised variational autoencoders for biomedical relation extraction","volume":"166","author":"Zhang","year":"2019","journal-title":"Methods"},{"key":"10.1016\/j.crphar.2021.100042_bib83","doi-asserted-by":"crossref","DOI":"10.1007\/s12539-020-00376-6","article-title":"Deep learning based drug screening for novel coronavirus 2019-nCov","author":"Zhang","year":"2020","journal-title":"Interdiscip Sci"},{"key":"10.1016\/j.crphar.2021.100042_bib84","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1021\/acs.jproteome.0c00129","article-title":"Of 2019-nCoV genome Refutes Snakes as its intermediate host and the unique similarity between its spike protein insertions and HIV-1","volume":"19","author":"Zhang","year":"2020","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.crphar.2021.100042_bib85","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","article-title":"Deep learning enables rapid identification of potent DDR1 kinase inhibitors","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.crphar.2021.100042_bib86","article-title":"COVID-2019 3C-like protease inhibitors designed using generative deep learning approaches","author":"Zhavoronkov","year":"2020","journal-title":"ChemRxiv Preprint"},{"key":"10.1016\/j.crphar.2021.100042_bib87","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/prot.25792","article-title":"Deep-learning contact-map guided protein structure prediction in CASP13","volume":"87","author":"Zheng","year":"2019","journal-title":"Proteins"},{"issue":"12","key":"10.1016\/j.crphar.2021.100042_bib88","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1016\/S2589-7500(20)30192-8","article-title":"Artificial intelligence in COVID-19 drug repurposing","volume":"2","author":"Zhou","year":"2020","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.crphar.2021.100042_bib89","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.crphar.2021.100042_bib90","article-title":"B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies","author":"Zhou","year":"2021","journal-title":"bioRxiv"}],"container-title":["Current Research in Pharmacology and Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590257121000298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590257121000298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:57:38Z","timestamp":1762923458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590257121000298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":90,"alternative-id":["S2590257121000298"],"URL":"https:\/\/doi.org\/10.1016\/j.crphar.2021.100042","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-370041\/v1","asserted-by":"object"}]},"ISSN":["2590-2571"],"issn-type":[{"value":"2590-2571","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Current Research in Pharmacology and Drug Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crphar.2021.100042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100042"}}